Skip to main content
Erschienen in: Current Cardiovascular Risk Reports 4/2015

01.04.2015 | Race + Ethnicity Disparities (K Watson and T Horwich, Section Editors)

The Role of Hypertension in Race-Ethnic Disparities in Cardiovascular Disease

verfasst von: Pelbreton C. Balfour Jr., Carlos J. Rodriguez, Keith C. Ferdinand

Erschienen in: Current Cardiovascular Risk Reports | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Race-ethnic disparities in cardiovascular disease (CVD) have persisted in the USA over the past few decades. Hypertension (HTN) is a significant contributor to CVD, including coronary heart disease, stroke, end-stage kidney disease and overall mortality and race-ethnic disparities in longevity. Additionally, both non-Hispanic blacks (NHBs) and Hispanic adults have been known to have higher prevalence of poorly controlled blood pressure compared to non-Hispanic whites (NHWs). Addressing these disparities has been a focus of programs such as the Million Hearts initiative. This review will provide an update of available data on HTN in various race-ethnic groups, including awareness, treatment, and control and note the recent progress in HTN control across all race/ethnic groups. We will also discuss the recent 2014 U.S. HTN guideline that has led to debate regarding the potential impact of BP goals in older persons on worsening CVD disparities, with disproportionate effects on women and NHBs.
Literatur
1.•
Zurück zum Zitat Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28–e292. This article from the American Heart Association provides the most recent epidemiological data regarding CVD in the US.CrossRefPubMed Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28–e292. This article from the American Heart Association provides the most recent epidemiological data regarding CVD in the US.CrossRefPubMed
2.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC). Health disparities and inequalities report—United States. MMWR Morb Mortal Wkly Rep. 2013;62 Suppl 3:157–60. Centers for Disease Control and Prevention (CDC). Health disparities and inequalities report—United States. MMWR Morb Mortal Wkly Rep. 2013;62 Suppl 3:157–60.
3.•
Zurück zum Zitat Fang J, Yang Q, Hong Y, Loustalot F. Status of cardiovascular health among adult Americans in the 50 States and the District of Columbia, 2009. J Am Heart Assoc. 2012;1(6):e005371. This article provides a recent update on the status of cardiovascular health metrics in the US.CrossRefPubMedCentralPubMed Fang J, Yang Q, Hong Y, Loustalot F. Status of cardiovascular health among adult Americans in the 50 States and the District of Columbia, 2009. J Am Heart Assoc. 2012;1(6):e005371. This article provides a recent update on the status of cardiovascular health metrics in the US.CrossRefPubMedCentralPubMed
4.
Zurück zum Zitat Hozawa A, Folsom AR, Sharrett AR, Chambless LE. Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects—atherosclerosis risk in communities study. Arch Intern Med. 2007;167(6):573–9.CrossRefPubMed Hozawa A, Folsom AR, Sharrett AR, Chambless LE. Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects—atherosclerosis risk in communities study. Arch Intern Med. 2007;167(6):573–9.CrossRefPubMed
5.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC). Racial/ethnic and socioeconomic disparities in multiple risk factors for heart disease and stroke—United States, 2003. MMWR Morb Mortal Wkly Rep. 2005;54(5):113–7. Centers for Disease Control and Prevention (CDC). Racial/ethnic and socioeconomic disparities in multiple risk factors for heart disease and stroke—United States, 2003. MMWR Morb Mortal Wkly Rep. 2005;54(5):113–7.
6.
Zurück zum Zitat Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6(4):e1000058.CrossRefPubMedCentralPubMed Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6(4):e1000058.CrossRefPubMedCentralPubMed
7.•
Zurück zum Zitat Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011–2012. NCHS Data Brief. 2013 Oct. This article provides a recent update on the prevalence of hypertension (HTN), along with awareness, treatment, and control among various race-ethnic groups in the US. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011–2012. NCHS Data Brief. 2013 Oct. This article provides a recent update on the prevalence of hypertension (HTN), along with awareness, treatment, and control among various race-ethnic groups in the US.
8.
Zurück zum Zitat Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for US adults: national health interview survey, 2012. Vital Health Stat. 2014;10. Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for US adults: national health interview survey, 2012. Vital Health Stat. 2014;10.
9.
Zurück zum Zitat Kramer H, Han C, Post W, Goff D, Diez-Roux A, Cooper R, et al. Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA). Am J Hypertens. 2004;17(10):963–70.CrossRefPubMed Kramer H, Han C, Post W, Goff D, Diez-Roux A, Cooper R, et al. Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA). Am J Hypertens. 2004;17(10):963–70.CrossRefPubMed
10.•
Zurück zum Zitat Rodriguez CJ, Allison M, Daviglus ML, Isasi CR, Keller C, Leira EC, et al. Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association. Circulation. 2014;130(7):593–625. This article provides an recent update on the CVD status of Hispanics/Latinos in the US along with an comprehensive review on psychosocial determinants of health as it pertains to Hispanics/Latinos in the US.CrossRefPubMed Rodriguez CJ, Allison M, Daviglus ML, Isasi CR, Keller C, Leira EC, et al. Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association. Circulation. 2014;130(7):593–625. This article provides an recent update on the CVD status of Hispanics/Latinos in the US along with an comprehensive review on psychosocial determinants of health as it pertains to Hispanics/Latinos in the US.CrossRefPubMed
11.•
Zurück zum Zitat Sorlie PD, Allison MA, Avilés-Santa ML, Cai J, Daviglus ML, Howard AG, et al. Prevalence of hypertension, awareness, treatment, and control in the Hispanic community health study/study of Latinos. Am J Hypertens. 2014;27(6):793–800. This article provides recent data on HTN among Hispanics/Latinos from the Hispanic Communities Health Study-Study of Latinos (HCHS/SOL), currently the largest cohort study of CVD in US Hispanics.CrossRefPubMed Sorlie PD, Allison MA, Avilés-Santa ML, Cai J, Daviglus ML, Howard AG, et al. Prevalence of hypertension, awareness, treatment, and control in the Hispanic community health study/study of Latinos. Am J Hypertens. 2014;27(6):793–800. This article provides recent data on HTN among Hispanics/Latinos from the Hispanic Communities Health Study-Study of Latinos (HCHS/SOL), currently the largest cohort study of CVD in US Hispanics.CrossRefPubMed
12.
Zurück zum Zitat Hertz RP, Unger AN, Cornell JA, Saunders E. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med. 2005;165(18):2098–104.CrossRefPubMed Hertz RP, Unger AN, Cornell JA, Saunders E. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med. 2005;165(18):2098–104.CrossRefPubMed
13.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC). Racial/Ethnic disparities in the awareness, treatment, and control of hypertension—United States, 2003–2010. MMWR Morb Mortal Wkly Rep. 2013;62(18):351–5. Centers for Disease Control and Prevention (CDC). Racial/Ethnic disparities in the awareness, treatment, and control of hypertension—United States, 2003–2010. MMWR Morb Mortal Wkly Rep. 2013;62(18):351–5.
14.
Zurück zum Zitat Romero CX, Romero TE, Shlay JC, Ogden LG, Dabelea D. Changing trends in the prevalence and disparities of obesity and other cardiovascular disease risk factors in three racial/ethnic groups of USA adults. Adv Prev Med. 2012 Romero CX, Romero TE, Shlay JC, Ogden LG, Dabelea D. Changing trends in the prevalence and disparities of obesity and other cardiovascular disease risk factors in three racial/ethnic groups of USA adults. Adv Prev Med. 2012
15.
Zurück zum Zitat Carson AP, Howard G, Burke GL, Shea S, Levitan EB, Muntner P. Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis. Hypertension. 2011;57(6):1101–7.CrossRefPubMedCentralPubMed Carson AP, Howard G, Burke GL, Shea S, Levitan EB, Muntner P. Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis. Hypertension. 2011;57(6):1101–7.CrossRefPubMedCentralPubMed
16.
Zurück zum Zitat Selassie A, Wagner CS, Laken ML, Ferguson ML, Ferdinand KC, Egan BM. Progression is accelerated from prehypertension to hypertension in blacks. Hypertension. 2011;58(4):579–87.CrossRefPubMedCentralPubMed Selassie A, Wagner CS, Laken ML, Ferguson ML, Ferdinand KC, Egan BM. Progression is accelerated from prehypertension to hypertension in blacks. Hypertension. 2011;58(4):579–87.CrossRefPubMedCentralPubMed
17.
Zurück zum Zitat Chobanian Aram V et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–52.CrossRefPubMed Chobanian Aram V et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–52.CrossRefPubMed
18.
Zurück zum Zitat Yoon SS, Burt V, Louis T, Carroll MD. Hypertension among adults in the United States, 2009–2010. NCHS Data Brief. 2012 Oct. Yoon SS, Burt V, Louis T, Carroll MD. Hypertension among adults in the United States, 2009–2010. NCHS Data Brief. 2012 Oct.
19.
Zurück zum Zitat Howard G, Prineas R, Moy C, Cushman M, Kellum M, Temple E, et al. Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic and Racial Differences in Stroke study. Stroke. 2006;37(5):1171–8.CrossRefPubMed Howard G, Prineas R, Moy C, Cushman M, Kellum M, Temple E, et al. Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic and Racial Differences in Stroke study. Stroke. 2006;37(5):1171–8.CrossRefPubMed
20.
Zurück zum Zitat Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010;303(20):2043–50.CrossRefPubMed Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010;303(20):2043–50.CrossRefPubMed
21.
Zurück zum Zitat Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011;124(9):1046–58.CrossRefPubMedCentralPubMed Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011;124(9):1046–58.CrossRefPubMedCentralPubMed
22.•
Zurück zum Zitat Egan BM, Li J, Hutchison FN, Ferdinand KC. Hypertension in the United States, 1999 to 2012: progress toward healthy people 2020 goals. Circulation. 2014;130(19):1692–9. This articles provides a recent update on HTN prevalence among race-ethnic groups and current status with respect to Health People 2020 established goals.CrossRefPubMed Egan BM, Li J, Hutchison FN, Ferdinand KC. Hypertension in the United States, 1999 to 2012: progress toward healthy people 2020 goals. Circulation. 2014;130(19):1692–9. This articles provides a recent update on HTN prevalence among race-ethnic groups and current status with respect to Health People 2020 established goals.CrossRefPubMed
23.
Zurück zum Zitat Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. Natl Vital Stat Rep. 2013;61(4):1–117.PubMed Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. Natl Vital Stat Rep. 2013;61(4):1–117.PubMed
24.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC). Vital signs: avoidable deaths from heart disease, stroke, and hypertensive disease—United States, 2001–2010. MMWR Morb Mortal Wkly Rep. 2013;62(35):721–7. Centers for Disease Control and Prevention (CDC). Vital signs: avoidable deaths from heart disease, stroke, and hypertensive disease—United States, 2001–2010. MMWR Morb Mortal Wkly Rep. 2013;62(35):721–7.
25.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC). Hypertension-related mortality among Hispanic subpopulations—United States, 1995–2002. MMWR Morb Mortal Wkly Rep. 2006;55(7):177–80. Centers for Disease Control and Prevention (CDC). Hypertension-related mortality among Hispanic subpopulations—United States, 1995–2002. MMWR Morb Mortal Wkly Rep. 2006;55(7):177–80.
26.
Zurück zum Zitat Chen J, Normand S-LT, Wang Y, Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998–2008. JAMA : the journal of the American Medical Association. 2011;306(15):1669–78.CrossRef Chen J, Normand S-LT, Wang Y, Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998–2008. JAMA : the journal of the American Medical Association. 2011;306(15):1669–78.CrossRef
27.•
Zurück zum Zitat Ferdinand KC, Elkayam U, Mancini D, Ofili E, Piña I, Anand I, et al. Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial. Am J Cardiol. 2014;114(1):151–9. This article provides a review on the management of heart failure, particularly in African Americans.CrossRefPubMed Ferdinand KC, Elkayam U, Mancini D, Ofili E, Piña I, Anand I, et al. Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial. Am J Cardiol. 2014;114(1):151–9. This article provides a review on the management of heart failure, particularly in African Americans.CrossRefPubMed
28.
Zurück zum Zitat Kalinowski L, Dobrucki IT, Malinski T. Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases. Circulation. 2004;109:2511e2517.CrossRef Kalinowski L, Dobrucki IT, Malinski T. Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases. Circulation. 2004;109:2511e2517.CrossRef
29.
Zurück zum Zitat Nesbitt S, Victor RG. Pathogenesis of hypertension in African Americans. Congest Heart Fail. 2004;10:24e29.CrossRef Nesbitt S, Victor RG. Pathogenesis of hypertension in African Americans. Congest Heart Fail. 2004;10:24e29.CrossRef
30.
Zurück zum Zitat Richardson AD, Piepho RW. Effect of race on hypertension and antihypertensive therapy. Int J Clin Pharmacol Ther. 2000;38:75e79.CrossRef Richardson AD, Piepho RW. Effect of race on hypertension and antihypertensive therapy. Int J Clin Pharmacol Ther. 2000;38:75e79.CrossRef
31.
Zurück zum Zitat Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D’Agostino RB, Kannel WB, et al. Framingham Heart Study. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068–72.CrossRefPubMed Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D’Agostino RB, Kannel WB, et al. Framingham Heart Study. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068–72.CrossRefPubMed
32.
Zurück zum Zitat Damasceno A, Mayosi BM, Sani M, Ogah OS, Mondo C, Ojji D, Dzudie A, Kouam CK, Suliman A, Schrueder N, Yonga G, Ba SA, Maru F, Alemayehu B, Edwards C, Davison BA, Cotter G, Sliwa K. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries: results of the Sub-Saharan Africa Survey of Heart Failure. Arch Intern Med 2012:1e9 Damasceno A, Mayosi BM, Sani M, Ogah OS, Mondo C, Ojji D, Dzudie A, Kouam CK, Suliman A, Schrueder N, Yonga G, Ba SA, Maru F, Alemayehu B, Edwards C, Davison BA, Cotter G, Sliwa K. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries: results of the Sub-Saharan Africa Survey of Heart Failure. Arch Intern Med 2012:1e9
33.
Zurück zum Zitat Bahrami H, Kronmal R, et al. Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med. 2008;168(19):2138–45.CrossRefPubMedCentralPubMed Bahrami H, Kronmal R, et al. Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med. 2008;168(19):2138–45.CrossRefPubMedCentralPubMed
34.
Zurück zum Zitat Kalogeropoulos A, Georgiopoulou V, Kritchevsky SB, Psaty BM, Smith NL, Newman AB, et al. Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study. Arch Intern Med. 2009;169(7):708–15.CrossRefPubMedCentralPubMed Kalogeropoulos A, Georgiopoulou V, Kritchevsky SB, Psaty BM, Smith NL, Newman AB, et al. Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study. Arch Intern Med. 2009;169(7):708–15.CrossRefPubMedCentralPubMed
35.•
Zurück zum Zitat Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606–19. This article provides estimates on the future incidence of heart failure in the US from the AHA.CrossRefPubMedCentralPubMed Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606–19. This article provides estimates on the future incidence of heart failure in the US from the AHA.CrossRefPubMedCentralPubMed
36.
Zurück zum Zitat Cruz-Flores S, Rabinstein A, Biller J, Elkind MS, Griffith P, Gorelick PB, et al. Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2091–116.CrossRefPubMed Cruz-Flores S, Rabinstein A, Biller J, Elkind MS, Griffith P, Gorelick PB, et al. Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2091–116.CrossRefPubMed
37.•
Zurück zum Zitat Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, Creager MA, Eckel RH, Elkind MS, Fornage M, Goldstein LB, Greenberg SM, Horvath SE, Iadecola C, Jauch EC, Moore WS, Wilson JA. Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2014 Oct 28. This article is the most recent guideline on the prevention of stroke from the AHA/American Stroke Association. Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, Creager MA, Eckel RH, Elkind MS, Fornage M, Goldstein LB, Greenberg SM, Horvath SE, Iadecola C, Jauch EC, Moore WS, Wilson JA. Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2014 Oct 28. This article is the most recent guideline on the prevention of stroke from the AHA/American Stroke Association.
38.
Zurück zum Zitat Rosamond WD, Folsom AR, Chambless LE, Wang CH, McGovern PG, Howard G, et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke. 1999;30:736–43.CrossRefPubMed Rosamond WD, Folsom AR, Chambless LE, Wang CH, McGovern PG, Howard G, et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke. 1999;30:736–43.CrossRefPubMed
39.
Zurück zum Zitat Zhang Y, Galloway JM, Welty TK, Wiebers DO, Whisnant JP, Devereux RB, et al. Incidence and risk factors for stroke in American Indians: the Strong Heart Study. Circulation. 2008;118:1577–84.CrossRefPubMedCentralPubMed Zhang Y, Galloway JM, Welty TK, Wiebers DO, Whisnant JP, Devereux RB, et al. Incidence and risk factors for stroke in American Indians: the Strong Heart Study. Circulation. 2008;118:1577–84.CrossRefPubMedCentralPubMed
40.
Zurück zum Zitat Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.CrossRefPubMed Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.CrossRefPubMed
41.•
Zurück zum Zitat James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20. This article is the most recently published HTN guideline from the Eight Joint National Committee.CrossRefPubMed James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20. This article is the most recently published HTN guideline from the Eight Joint National Committee.CrossRefPubMed
42.•
Zurück zum Zitat Krakoff LR, Gillespie RL, Ferdinand KC, Fergus IV, Akinboboye O, Williams KA, et al. 2014 hypertension recommendations from the eighth joint national committee panel members raise concerns for elderly black and female populations. J Am Coll Cardiol. 2014;64(4):394–402. This article is a state of the art review discussing the most recently published HTN guideline and viewpoints of two major writing groups in discordance with the new guidelines.CrossRefPubMed Krakoff LR, Gillespie RL, Ferdinand KC, Fergus IV, Akinboboye O, Williams KA, et al. 2014 hypertension recommendations from the eighth joint national committee panel members raise concerns for elderly black and female populations. J Am Coll Cardiol. 2014;64(4):394–402. This article is a state of the art review discussing the most recently published HTN guideline and viewpoints of two major writing groups in discordance with the new guidelines.CrossRefPubMed
43.
Zurück zum Zitat Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm Jr RH, et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010;56(5):780–800.CrossRefPubMed Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm Jr RH, et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010;56(5):780–800.CrossRefPubMed
44.
Zurück zum Zitat Ritchey MD, Wall HK, Gillespie C, George MG, Jamal A. Division for Heart Disease and Stroke Prevention, CDC. Million hearts: prevalence of leading cardiovascular disease risk factors—United States, 2005–2012. MMWR Morb Mortal Wkly Rep. 2014;63(21):462–7.PubMed Ritchey MD, Wall HK, Gillespie C, George MG, Jamal A. Division for Heart Disease and Stroke Prevention, CDC. Million hearts: prevalence of leading cardiovascular disease risk factors—United States, 2005–2012. MMWR Morb Mortal Wkly Rep. 2014;63(21):462–7.PubMed
45.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC). Million hearts: strategies to reduce the prevalence of leading cardiovascular disease risk factors—United States, 2011. MMWR Morb Mortal Wkly Rep. 2011;60(36):1248–51. Centers for Disease Control and Prevention (CDC). Million hearts: strategies to reduce the prevalence of leading cardiovascular disease risk factors—United States, 2011. MMWR Morb Mortal Wkly Rep. 2011;60(36):1248–51.
46.
Zurück zum Zitat Ferdinand KC, Patterson KP, Taylor C, Fergus IV, Nasser SA, Ferdinand DP. Community-based approaches to prevention and management of hypertension and cardiovascular disease. J Clin Hypertens (Greenwich). 2012;14(5):336–43.CrossRef Ferdinand KC, Patterson KP, Taylor C, Fergus IV, Nasser SA, Ferdinand DP. Community-based approaches to prevention and management of hypertension and cardiovascular disease. J Clin Hypertens (Greenwich). 2012;14(5):336–43.CrossRef
47.
Zurück zum Zitat Victor RG, Ravenell JE, Freeman A, Leonard D, Bhat DG, Shafiq M, et al. Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med. 2011;171(4):342–50.CrossRefPubMedCentralPubMed Victor RG, Ravenell JE, Freeman A, Leonard D, Bhat DG, Shafiq M, et al. Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med. 2011;171(4):342–50.CrossRefPubMedCentralPubMed
48.
Zurück zum Zitat Yancy CW, Wang TY, Ventura HO, Piña IL, Vijayaraghavan K, Ferdinand KC, et al. The coalition to reduce racial and ethnic disparities in cardiovascular disease outcomes (credo): why credo matters to cardiologists. J Am Coll Cardiol. 2011;57(3):245–52.CrossRefPubMed Yancy CW, Wang TY, Ventura HO, Piña IL, Vijayaraghavan K, Ferdinand KC, et al. The coalition to reduce racial and ethnic disparities in cardiovascular disease outcomes (credo): why credo matters to cardiologists. J Am Coll Cardiol. 2011;57(3):245–52.CrossRefPubMed
49.
Zurück zum Zitat Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved blood pressure control associated with a large-scale hypertension program. JAMA. 2013;310(7):699–705.CrossRefPubMedCentralPubMed Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved blood pressure control associated with a large-scale hypertension program. JAMA. 2013;310(7):699–705.CrossRefPubMedCentralPubMed
Metadaten
Titel
The Role of Hypertension in Race-Ethnic Disparities in Cardiovascular Disease
verfasst von
Pelbreton C. Balfour Jr.
Carlos J. Rodriguez
Keith C. Ferdinand
Publikationsdatum
01.04.2015
Verlag
Springer US
Erschienen in
Current Cardiovascular Risk Reports / Ausgabe 4/2015
Print ISSN: 1932-9520
Elektronische ISSN: 1932-9563
DOI
https://doi.org/10.1007/s12170-015-0446-5

Weitere Artikel der Ausgabe 4/2015

Current Cardiovascular Risk Reports 4/2015 Zur Ausgabe

Elderly + Heart Disease (J Wei, Section Editor)

The Demographics of Aging and Its Impact on the Cardiovascular Health

Genetics, Environment, Behavior and Risk Reduction (S Padmanabhan, Section Editor)

The Early Life Origins of Cardiovascular Disease

Diabetes + Insulin Resistance (M Rutter, Section Editor)

Statins and Incident Diabetes: Can Risk Outweigh Benefit?

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.